Zyax Chem Buys 26 Percent Stake in Gaymed Labs
Zyax Chem acquires 26 percent stake in Gaymed Labs, securing board representation and boosting expansion in the ophthalmic segment.
Zyax Chem Stake Acquisition | 22/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy